Medullary thyroid carcinoma: the influence of policy changing in clinical characteristics and disease progressionMaria Alevizaki, E. Anastasiou, Katerina Saltiki et al.|European Journal of Endocrinology|2012Cited by 22
The Pro<sup>12</sup>Ala PPARγ gene polymorphism: possible modifier of the activity and severity of thyroid‐associated orbitopathy (TAO)Maria Alevizaki, Wilmar M. Wiersinga, Adriana Cimponeriu et al.|Clinical Endocrinology|2008Cited by 17
Thyroid volume, selenium levels and nutritional habits in a rural region in AlbaniaJohn Doupis, Maria Alevizaki, Charalambos Stavrianos et al.|HORMONES|2009Cited by 15
Subjects homozygous for the BCL1 polymorphism of glucocorticoid receptor gene may have an increased risk for impaired endothelial functionKimon Stamatelopoulos, Maria Alevizaki, Katerina Saltiki et al.|12th European Congress of Endocrinology|2010Cited by 3
Local treatments and TKI efficacy in radioiodine refractory differentiated thyroid carcinoma patients: a single center experienceKaterina Saltiki, Maria Alevizaki, Olga Karapanou et al.|Endocrine Related Cancer|2025Cited by 1